Journal profile · Medicine-Biochemistry (medical)
EPMA Journal
ISSN 1878-5085 · Springer International Publishing · United Kingdom · 4 issues per year · Founded 2010
EPMA Journal: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 6.98; fully open access; APC about USD 2,890; median 72 days to acceptance (88 articles, last 24 months); 39 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
EPMA Journal is published by Springer International Publishing and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Retinal Diseases and Treatments, Cardiovascular Health and Risk Factors and Glaucoma and retinal disorders, together about 21.5% of its articles. (generated from OpenAlex topic counts and CAS ranking data)
EPMA Journal is a journal of predictive, preventive and personalised medicine (PPPM). EPMA publishes results and achievements in the context of innovative approaches to:A. predictive diagnostics B. targeted prevention and C. personalisation of medical services to the patient in focusAppropriate presentation of PPPM concepts is the major criterion for considering submitted manuscripts by the EPMA J. Authors are kindly requested to read and refer to the PPPM related publications demonstrating progress in a corresponding field and providing clear statements for how the presented results and / or reviewed achievements in the field (may) effectively contribute to the paradigm shift from reactive medicine (delayed medical services) to the advanced approach by utilising PPPM concepts. Manuscripts not including PPPM concepts and not operating with the keywords "predictive, preventive and personalised medicine" will not be considered.
From the journal's Aims & Scope
Research area (LetPub): Medicine-Biochemistry (medical)
Editor-in-chief Olga GolubnitschajaPublisher website
Editorial board by country: 2 in mainland China (about 7%); most named Germany 5, United States 3, Mainland China 2, Belgium 2, Czechia 2 (30 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Retinal Diseases and TreatmentsMedicine7.8%
- Cardiovascular Health and Risk FactorsMedicine7%
- Glaucoma and retinal disordersMedicine6.7%
- Nutrition, Genetics, and DiseaseBiochemistry, Genetics and Molecular Biology5.7%
- Health, Environment, Cognitive AgingEnvironmental Science5.4%
- Gut microbiota and healthBiochemistry, Genetics and Molecular Biology5%
- Retinal Imaging and AnalysisMedicine5%
- Health Systems, Economic Evaluations, Quality of LifeEconomics, Econometrics and Finance4.8%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Medicine, Research & Experimental | Zone 2 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
EmbaseCAB AbstractsCurrent ContentsPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 6.98LetPub ·
- Impact factor (publisher) 2025
- 7Publisher website ·
- 5-year impact factor (publisher) 2025
- 6.5Publisher website ·
- CiteScore 2026-06
- 11.4LetPub ·
- SJR 2026-06
- 1.55LetPub ·
- SNIP 2026-06
- 1.54LetPub ·
- h-index
- 26LetPub ·
- h-index
- 73OpenAlex ·
- i10-index
- 442OpenAlex ·
- 2-year mean citedness
- 8.6OpenAlex ·
- Self-citation rate
- 18.6%LetPub ·
- Share of gold OA articles
- 36.89%LetPub ·
Volume
- Articles per year
- 39LetPub ·
- Articles per year (publisher)
- 2,025Publisher website ·
- Downloads per year (publisher) 2025
- 514800Publisher website ·
Articles by year OpenAlex count · 796 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 37 | 37 | 28 |
| 2025 | 39 | 32 | 287 |
| 2024 | 44 | 44 | 717 |
| 2023 | 39 | 39 | 1,064 |
| 2022 | 44 | 44 | 1,134 |
| 2021 | 36 | 36 | 1,650 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
72 daysMedian, submission to acceptance · P25–P75 40 days – 91 days
- Acceptance to online
- median 16 days (88 articles)
- Submission to online
- median 89 days
- Sample
- 88 articles with submission and acceptance dates (90 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Submission to first decision
- 8 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Fully open accessLetPub
Every article is open access; authors usually pay an article processing charge (APC).
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 2,890 / EUR 4,590 | — | — |
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare3 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Reference style
- Numbered, in order of citation
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Open access, Peer review
- AI use Generative AI Images
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Author Contributions
Authors are encouraged to include a statement that specifies the contribution of every author to the research and preparation of the manuscript.
Source ↗Publisher website ·- Conflicts of interest Competing Interests
Authors are requested to disclose interests that are directly or indirectly related to the work submitted for publication. Interests within the last 3 years of beginning the work (conducting the research and preparing the work for submission) should be reported. Interests outside the 3-year time frame must be disclosed if they could reasonably be perceived as influencing the submitted work. Disclo…
Source ↗Publisher website ·- Data availability Data Availability
This journal encourages authors to provide an optional statement of data availability in their article. Data Availability Statements should include information on where data supporting the results reported in the article can be found, including, where applicable, hyperlinks to publicly archived datasets analysed or generated during the study. Data availability statements can also indicate whether …
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in EPMA Journal, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Peer review
Manuscript submission implies originality, not under consideration elsewhere, and approval by all co-authors and responsible authorities. Model summary
Submission of a manuscript implies: that the work described has not been published before; that it is not under consideration for publication anywhere else; that its publication has been approved by all co-authors, if any, as well as by the responsible authorities – tacitly or explicitly – at the institute where the work has been carried out.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer International Publishing
- Country or region
- United Kingdom
- Language
- English
- Frequency
- 4 issues per year
- Founded
- 2010
- ISSN
- 1878-5085
- Society / sponsor
- European Association for Predictive
- Latest issue on the website
- Volume 17, Issue 3 (September 2026)
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Author guidelines ↗LetPub
- Special issues ↗Publisher website
FAQ
Frequently asked questions about EPMA Journal
What CAS zone is EPMA Journal in?
In the 2025 upgraded edition of the CAS Journal Ranking, EPMA Journal is in Zone 2 of Medicine, and in Zone 2 of the minor category Medicine, Research & Experimental. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of EPMA Journal?
The latest impact factor listed by LetPub is 6.98; CiteScore 11.4, h-index 73.
How long does peer review take at EPMA Journal?
Based on the dates recorded on 88 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 72 days (interquartile range 40–91 days). Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of EPMA Journal?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Reference style: Numbered, in order of citation. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of EPMA Journal based?
Of the 30 board members whose country the journal's board page names, 2 (about 7%) are in mainland China; the countries named most often are Germany (5), United States (3) and Mainland China (2). Counted from the institutions listed on the board page; for reference only.
Which databases index EPMA Journal?
According to LetPub and DOAJ records, EPMA Journal is indexed in SCIE and Scopus. The journal's website also lists Embase, CAB Abstracts and Current Contents; that list has not been checked against each database.
Is EPMA Journal open access, and what is the APC?
EPMA Journal is a fully open-access journal. APC about USD 2,890.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .